Features Partner Sites Information LinkXpress
Sign In

Approval of Expansion of Cardioverter Defibrillator Trial to Include MRI Full-Body Scans

By Medimaging International staff writers
Posted on 03 Jun 2014
Print article
A new magnetic resonance imaging (MRI)-compatible, implantable cardioverter defibrillators (ICDs) provide physicians with the complete diagnostic capabilities of a dual-chamber ICD, including atrial sensing and sophisticated shock reduction algorithms with only one lead.

Biotronik (Berlin, Germany), a manufacturer of cardiovascular medical devices, reported that the US Food and Drug Administration (FDA) has approved a significant expansion of its ongoing ProMRI trial. The approval will allow patients enrolled in phase C of the trial to receive full-body scans, and for the first time, include patients with DX ICDs in the study.

Biotronik, in 2011, received CE marking of approval and became the first company worldwide with an ICD approved for use in a MRI scanner. The ProMRI study is the next step in making this technology widely available in the United States. Biotronik introduced DX technology in 2013 in the United States, and it has been rapidly accepted by US electrophysiologists. Patients prefer implants with less hardware while physicians benefit from dual-chamber diagnostic data.

“With the DX system, I gain important diagnostic and therapeutic information. For my primary prevention patients with no dual chamber pacing indication, the implant procedures are straightforward, and it makes sense to use as little hardware as possible,” said Harpreet S. Grewal, MD, FACC, FHRS, from Richmond Cardiology Associates (Richmond, VA, USA). “The potential to provide this therapy and have it approved for use in full-body MRI conditions adds clinical value.”

Phase C of the ProMRI trial is the final phase in a series of MRI compatibility trials conducted by Biotronik in rapid succession. Phase A and phase B of the trial evaluated the safety of Biotronik Entovis pacemaker systems during MRI scans. Phase A resulted in FDA approval on May 6, 2014, of Entovis systems for MRI scans with an exclusion zone. Phase B expanded the trial to evaluate the safety of Entovis pacemaker systems for full-body scans, including cardiac and thoracic spinal scans. Phase B is nearing completion and data will soon be submitted to FDA.

“We are anxiously awaiting the day when this important diagnostic capability, up to now only available to pacemaker patients, can also benefit ICD patients,” said Kevin Mitchell, vice president, clinical studies at Biotronik, Inc. “Biotronik is committed to extending its ProMRI technology to as many patients as possible. We were the first company to offer ICD patients in the United States MRI access, and remain the only company that provides single-chamber pacemaker patients access to this diagnostic tool.”

Every year, about 200,000 patients in the United States are implanted with ICDs, and studies estimate that 50%–75% of them will develop a clinical need for an MRI scan during their lifetime. MRI scans frequently provide improved diagnostic capabilities for specific that cannot be adequately examined by X-ray, computed tomography (CT), or ultrasound. The strong forces applied during an MRI scan can have a negative effect on both device and patient, and are usually contraindicated for pacemaker and ICD patients.

With its ProMRI technology, Biotronik has developed a solution to enable all cardiac rhythm patients’ access to MRI scanning. ProMRI technology is already used widely in Europe, including recent CE approval for MR-Conditional full-body and 3.0 Tesla scans with the Ilesto/Iforia ICD system. The Biotronik -sponsored trial has been in US subject recruitment since March 2013.

Related Links:


Print article



view channel
Image: New Scenaria SE 64/128-slice Computed Tomography Scanner from Hitachi Medical Systems America (Photo courtesy of Business Wire).

Two new 64/128-Slice CT Scanners Cleared by the FDA

A major diagnostic imaging equipment provider has announced US FDA clearance of two new 64/128-slice Computed Tomography (CT) scanners. The Food and Drug Administration (FDA; Silver Spring, MD, USA)... Read more


view channel

Fast, Noninvasive Assessment of Chronic Liver Disease Announced as Alternative to Biopsies

A leading ultrasound imaging vendor has presented the clinical benefits of its innovative technology for noninvasive assessment of the severity of liver fibrosis, at the Liver Meeting 2015, in San Francisco (CA, USA). Researchers have published more than 60 items on the reliability and effectiveness of the new technology.... Read more

Nuclear medicine

view channel
Image: Glioblastoma in a PET scanner with (left) and without (right) the YY146 marker (Photo courtesy of Weibo Cai, WISC).

Antibody Cancer Marker Causes Tumors to Light Up

A novel marker attaches to a molecule on highly aggressive brain cancer, resulting in glioblastoma tumor tissue being easily identified in a positron emission tomography (PET) scanner. Developed by... Read more

Imaging IT

view channel
Image: 3D scan a child’s heart born with congenital heart defects (Photo courtesy of the Phoenix Children’s Hospital).

3D Modeling System Accurately Predicts Pediatric Donor Heart Volumes

A new three dimensional (3D) computer modeling system may more accurately identify the best donor heart for a pediatric transplant patient. To develop the new 3D system, researchers at Arizona State... Read more

Industry News

view channel

Long-Term Strategic Managed Medical Equipment Services Partnership Announced

An 18-year strategic collaboration agreement, worth CAD 300 million, between a major medical imaging vendor and the Southwest York Region of Ontario in Canada, has been announced. The partnership is for managed equipment services to help advance medical technology in the Southwest York region, and to expand the accessibility... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.